Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Cancer Pain × Donepezil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Radiation Injuries 2 Small Cell Lung Carcinoma 1 Pinealoma 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive 1 Neoplasm Metastasis 1 Meningioma 1 Memory Disorders 1 Medulloblastoma 1 Lung Neoplasms 1 Gliosarcoma 1 Glioma, Subependymal 1 Glioma 1 Glioblastoma 1 Fatigue 1 Ependymoma 1 Depression 1 Delirium 1 Craniopharyngioma 1 Cognitive Dysfunction 1 Choroid Plexus Neoplasms 1 Cancer Pain 1 Breast Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Morphine 5 nabiximols 3 Oxycodone 2 Methadone 2 Hydromorphone 2 Acetaminophen 2 tanezumab 1 resiniferatoxin 1 naloxegol 1 Tapentadol 1 Sugars 1 Standard of Care 1 Lidocaine 1 Inosine Monophosphate 1 Fentanyl 1 Donepezil 1 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00352664 2016-05-09

The Effect of Donepezil on Sedation and Other Symptoms

M.D. Anderson Cancer Center

Phase 3 Terminated

27 enrolled 2 charts

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡